Stiolto respimat and Sumatriptan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Stiolto respimat (olodaterol hydrochloride; tiotropium bromide) and Sumatriptan (sumatriptan succinate). Common drug interactions include hereditary angioedema among females and palpitations among males.

The phase IV clinical study analyzes what interactions people have when they take Stiolto respimat and Sumatriptan. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Stiolto respimat?

Stiolto respimat has active ingredients of olodaterol hydrochloride; tiotropium bromide. eHealthMe is studying from 4,438 Stiolto respimat users. Check the latest studies of Stiolto respimat.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

On Jul, 09, 2026

13 people who take Stiolto respimat and Sumatriptan together, and have interactions are studied.

Stiolto respimat and Sumatriptan drug interactions.

What are the common drug interactions of Stiolto Respimat and Sumatriptan, by gender? *:

female:

Hereditary angioedema (recurrent episodes of severe swelling)
Gastric ulcer (stomach ulcer)
Headache (pain in head)
Influenza
Infusion site erythema (reddening of the skin at infusion site)
Infusion site swelling
Memory impairment
Oropharyngeal pain
Pneumonia
Rhinitis allergic (inflammation of the nasal airways due to allergy)

male:

Palpitations (feelings or sensations that your heart is pounding or racing)

What are the common drug interactions of Stiolto Respimat and Sumatriptan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anxiety
Depression
Emotional disorder
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Mood swings (an extreme or rapid change in mood)
Suicidal ideation

40-49:

Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Central pain syndrome (neurological condition caused by damage or malfunction in the central nervous system)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Dizziness
Gastric ulcer (stomach ulcer)
Influenza
Lip injury
Memory impairment
Rhinitis allergic (inflammation of the nasal airways due to allergy)
Therapeutic response unexpected

50-59:

n/a

60+:

Hereditary angioedema (recurrent episodes of severe swelling)
Flushing (the warm, red condition of human skin)
Headache (pain in head)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site swelling
Abdominal pain upper
Influenza

What are the existing conditions these people have? *

Hereditary Angioedema (recurrent episodes of severe swelling): 6 people, 46.15%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 15.38%
Immune System Disorder: 2 people, 15.38%
Headache (pain in head): 2 people, 15.38%
Drowsiness: 2 people, 15.38%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 15.38%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 7.69%
Multiple Allergies (allergy to multiple agents): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Stiolto respimat and Sumatriptan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously